1. (1978). Proceedings of the First Scarborough Converence -- Screening for Neural Tube Defects in the United States. Scarborough, ME, Foundation for Blood Research.
2. ACOG. (2012). Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. American College of Obstetricians and Gynecologists Obstet Gynecol, 120(6), 1532–1534.
3. Benn, P., Borell, A., Chiu, R., Cuckle, H., Dugoff, L., Faas, B., et al. (2013). Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenatal Diagnosis, 33(7), 622–629.
4. Deatrick, D., Aalberg, J. & Cawley, J. (2010). A guide to creating and evaluating patient materials. Guidelines for effective print communication. Retrieved July 22, 2014, from http://www.cancerpatienteducation.org/health-literacy/alternate-document/Maine_Health_Guidelines_for_Effective_Print_Communication.pdf .
5. Devers, P. L., Cronister, A., Ormond, K. E., Facio, F., Brasington, C. K., & Flodman, P. (2013). Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. Journal of Genetic Counseling, 22(3), 291–295.